556 related articles for article (PubMed ID: 26600119)
1. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
[TBL] [Abstract][Full Text] [Related]
2. Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII.
Jadhav SB; Reddy PS; Narayanan KL; Bhosale PN
Sci Pharm; 2017 Jun; 85(3):. PubMed ID: 28653975
[TBL] [Abstract][Full Text] [Related]
3. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
4. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
[TBL] [Abstract][Full Text] [Related]
5. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
[TBL] [Abstract][Full Text] [Related]
6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Related Substances of Ketoprofen and Omeprazole in Combined Capsule Dosage Form.
Koppala S; Reddy VR; Anireddy JS
J Chromatogr Sci; 2016; 54(5):765-75. PubMed ID: 26860397
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
9. Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation.
Prakash L; Himaja M; Vasudev R
Sci Pharm; 2015; 83(1):65-83. PubMed ID: 26839802
[TBL] [Abstract][Full Text] [Related]
10. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
11. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments.
Murthy MV; Krishnaiah Ch; Srinivas K; Rao KS; Kumar NR; Mukkanti K
J Pharm Biomed Anal; 2013 Jan; 72():40-50. PubMed ID: 23146225
[TBL] [Abstract][Full Text] [Related]
14. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
[TBL] [Abstract][Full Text] [Related]
15. Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation.
Katakam LNR; Dongala T; Ettaboina SK
Biomed Chromatogr; 2021 May; 35(5):e5062. PubMed ID: 33410554
[TBL] [Abstract][Full Text] [Related]
16. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the stability indicating RP-UHPLC method for the determination of the chemical purity and assay of bimatoprost.
Zezula M; Ruszczak M; Maruszak W; Zagrodzka J; Chodynski M; Dams I
J Pharm Biomed Anal; 2019 Sep; 174():348-359. PubMed ID: 31202877
[TBL] [Abstract][Full Text] [Related]
18. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
Weng RW; Wang XT; Wen HL; Liu H
Se Pu; 2024 Apr; 42(5):432-444. PubMed ID: 38736386
[TBL] [Abstract][Full Text] [Related]
19. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
Vijayabaskar S; Mahalingam V; Kalaivani
J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
[TBL] [Abstract][Full Text] [Related]
20. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
